Torrent Pharmaceuticals
Torrent Pharmaceuticals Ltd is an India-based pharmaceutical company engaged in the research, development, production, and marketing of branded generic medicines. The company specializes in therapeutic segments including cardiovascular, central nervous system, gastrointestinal, diabetology, and oncology treatments. Principal revenue drivers stem from prescription drug sales across branded generic retail markets and institutional healthcare tenders. End markets cover healthcare providers, pharmacies, and retail consumers in India, Brazil, Germany, the United States, and emerging markets. Torrent Pharmaceuticals holds a prominent position in India's chronic therapy market, supported by international manufacturing operations. The company is headquartered in Ahmedabad, India, and its shares are listed on the National Stock Exchange of India and the BSE.
23 of the funds FundTelligence covers report a position in Torrent Pharmaceuticals.
- Legal name
- Torrent Pharmaceuticals Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 23
Funds holding Torrent Pharmaceuticals
- Polar Capital Healthcare Opportunities Fund — Polar Capital · 4.5 % (largest positions only, October 2026)
- Aberdeen Indian Equity Fund — Abrdn · 3.8 % (largest positions only, September 2026)
- Franklin India Fund — Franklin Templeton · 1.98 % (full portfolio disclosed, September 2026)
- Nordea India — Nordea Funds · 1.85 % (full portfolio disclosed, September 2026)
- Handelsbanken Asia SMB — Handelsbanken · 0.87 % (full portfolio disclosed, August 2026)
- Danske Invest Emerging Markets Sustainable Future — Danske Invest · 0.44 % (full portfolio disclosed, September 2026)
- Danske Invest Global Emerging Markets — Danske Invest · 0.43 % (full portfolio disclosed, September 2026)
- Storebrand Emerging Markets Plus — Storebrand · 0.14 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 23 funds holding it.